These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 347908)

  • 41. Remarkable potency of somatostatin as a glucagon suppressant.
    Samols E; Harrison J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1495-7. PubMed ID: 790096
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.
    Tannenbaum GS
    Endocrinology; 1981 Jan; 108(1):76-82. PubMed ID: 6109623
    [No Abstract]   [Full Text] [Related]  

  • 43. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Correlations between prostaglandins and secretion of insulin, glucagon and somatotropic hormone. Effects of treatment with acetylsalicylic acid].
    Sportiello V; Fernandes D; Pace M
    Clin Ter; 1981 Aug; 98(3):299-308. PubMed ID: 7026140
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.
    Pless J; Bauer W; Briner U; Doepfner W; Marbach P; Maurer R; Petcher TJ; Reubi JC; Vonderscher J
    Scand J Gastroenterol Suppl; 1986; 119():54-64. PubMed ID: 2876507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of L-tryptophan load on endocrine system of pancreas in diabetes mellitus.
    Martinsone D; Ligere R; Martinsons A
    Adv Exp Med Biol; 1996; 398():413-6. PubMed ID: 8906297
    [No Abstract]   [Full Text] [Related]  

  • 47. Secretion of somatostatin and its physiologic function.
    Reichlin S
    J Lab Clin Med; 1987 Mar; 109(3):320-6. PubMed ID: 2880918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Islet cell functional pathology.
    Lacy PE
    Pathol Annu; 1977; 12 Pt 1():1-15. PubMed ID: 199881
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome.
    Fallucca F; Delle Fave G; Giangrande L; Del Balzo P; De Magistris L; Carratù R
    J Endocrinol Invest; 1981; 4(4):451-3. PubMed ID: 6120969
    [No Abstract]   [Full Text] [Related]  

  • 51. Regulating glucagon secretion: somatostatin in the spotlight.
    Rutter GA
    Diabetes; 2009 Feb; 58(2):299-301. PubMed ID: 19171745
    [No Abstract]   [Full Text] [Related]  

  • 52. Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187.
    Fujimoto WY; Ensinck JW
    Endocrinology; 1976 Jan; 98(1):259-62. PubMed ID: 765117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological actions of prosomatostatin.
    Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatostatin--a regulatory peptide of clinical importance.
    Bethge N; Diel F; Usadel KH
    J Clin Chem Clin Biochem; 1982 Sep; 20(9):603-13. PubMed ID: 6128369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatostatin: a metabolic regulator.
    Dileepan KN; Wagle SR
    Life Sci; 1985 Dec; 37(25):2335-43. PubMed ID: 2867445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications.
    Lefèbvre PJ; Paolisso G; Scheen AJ; Henquin JC
    Diabetologia; 1987 Jul; 30(7):443-52. PubMed ID: 3311858
    [No Abstract]   [Full Text] [Related]  

  • 58. Insulin and glucagon secretion from rat islets maintained in a tissue culture-perifusion system.
    Gingerich RL; Aronoff SL; Kipnis DM; Lacy PE
    Diabetes; 1979 Apr; 28(4):276-81. PubMed ID: 374172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes.
    Weir GC; Bonner-Weir S
    J Clin Invest; 1990 Apr; 85(4):983-7. PubMed ID: 1969425
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of glucagon and somatostatin in insulin release.
    Taniguchi H; Murakami K; Tsutou A; Tamagawa M; Ejiri K; Yoshioka M; Utsumi M; Morita S; Baba S
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():103-7. PubMed ID: 6112139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.